Validating CGM for GDM
ConditionGestational Diabetes Mellitus (GDM)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorIcahn School of Medicine at Mount Sinai
About this trial
This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.
Eligibility criteria
Qualifiers
Ages 18-50
Singleton pregnancy between 24-32 weeks gestational age
Prenatal care and delivery at Mount Sinai Hospital
Disqualifiers
Multiple fetal gestation
Preexisting diabetes
Concurrent use of steroids
Anomalous fetus
Trial design
Treatments tested in this trial
- Continuous glucose monitor
Treatment groups
150 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov